Artemisinin-based combination therapies and their introduction in Japan.

Author: KanoShigeyuki

Paper Details 
Original Abstract of the Article :
Artemisinin was discovered in 1971 from a herb, Artemisia annua, which had been used for more than 2,000 years in China against intermittent fever. Now, the artemisinin and its derivatives have become essential components of artemisinin-based combination therapies (ACTs). The ACTs are the recommende...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://pubmed.ncbi.nlm.nih.gov/24979951

データ提供:米国国立医学図書館(NLM)

The Role of Artemisinin-Based Combination Therapies in Malaria Treatment

Malaria, a deadly disease caused by parasites transmitted through mosquito bites, has plagued humanity for centuries. The discovery of artemisinin, a potent antimalarial drug derived from a Chinese herb, revolutionized the treatment of malaria. This study delves into the fascinating history of artemisinin and explores the development and effectiveness of artemisinin-based combination therapies (ACTs). The study examines the reasons why ACTs are now the recommended first-line treatment for malaria, highlighting their efficacy, speed of parasite clearance, and relatively low occurrence of side effects.

ACTs: A Promising Weapon Against Malaria

ACTs have proven to be highly effective in treating all four types of human malaria. They are particularly important in cases of severe falciparum malaria, including cerebral malaria, which can be fatal. The study emphasizes the urgent need to introduce ACTs into Japan, where malaria has been eradicated but is increasingly being imported through travel. Despite the absence of registered ACTs in Japan, the study cites several clinical trials that have demonstrated their efficacy in treating imported malaria cases.

The Need for Continued Research and Access

This research underscores the importance of global collaboration in combating infectious diseases. The successful development of ACTs serves as a testament to the power of scientific advancements. However, the study highlights the need for continued research and development of new antimalarial drugs to address emerging drug resistance and improve treatment options. Furthermore, the study emphasizes the importance of ensuring access to effective antimalarial medications for all populations, regardless of their location or socioeconomic status. This is a vital step towards eradicating malaria and improving global health.

Dr. Camel's Conclusion

This research is like a shimmering oasis in the vast desert of malaria research! The discovery of artemisinin and the development of ACTs represent a significant breakthrough in the fight against this devastating disease. The study's call for the introduction of ACTs into Japan is a powerful reminder that we must continue to strive for global access to effective treatments.

Date :
  1. Date Completed 2014-08-06
  2. Date Revised 2021-09-15
Further Info :

Pubmed ID

24979951

DOI: Digital Object Identifier

24979951

Related Literature

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.